Iceland vs Tanzania, United Republic of: Share of adolescent girls vaccinated against human papillomavirus
Iceland
93.0%
in 2024
Tanzania, United Republic of
99.0%
in 2024
Iceland rank
4th
Tanzania, United Republic of rank
1st
Share of adolescent girls vaccinated against human papillomavirus over time
- Iceland
- Tanzania, United Republic of
How they compare
Tanzania, United Republic of currently reports 99.0% against 93.0% in Iceland, a difference of 6.0%.
That makes Tanzania, United Republic of's figure about 1.1 times Iceland's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Iceland ahead.
Iceland ranks 4th and Tanzania, United Republic of ranks 1st of 74 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.0% | 16.0% | 70.0% | Iceland |
| 2020s | 91.2% | 62.8% | 28.4% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Iceland or Tanzania, United Republic of?
- Tanzania, United Republic of, at 99.0% against 93.0% in Iceland as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Iceland and Tanzania, United Republic of?
- 6.0%, with Tanzania, United Republic of ahead.
- How many years of comparable data are there for Iceland and Tanzania, United Republic of?
- 6 years are reported by both, from 2019 to 2024.
- How do Iceland and Tanzania, United Republic of rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Iceland ranks 4th and Tanzania, United Republic of ranks 1st of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.